Patents by Inventor Paul RAKESH

Paul RAKESH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydro-benzoazepine glycosidase inhibitors
    Patent number: 11795165
    Abstract: Compounds of formula (I?), wherein A, R1, R2, T1, T2, T3, T4, L, W, Z, R??, m and n have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
    Type: Grant
    Filed: August 22, 2019
    Date of Patent: October 24, 2023
    Assignee: Asceneuron SA
    Inventors: Anna Quattropani, Santosh S. Kulkarni, Awadut Gajendra Giri, Grant Wishart, Paul Rakesh
  • Spiro compounds as glycosidase inhibitors
    Patent number: 11731972
    Abstract: Compounds of formula (I), wherein A, R, L, Z, Q1, Q2 and n have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
    Type: Grant
    Filed: August 22, 2019
    Date of Patent: August 22, 2023
    Assignee: Asceneuron SA
    Inventors: Anna Quattropani, Santosh S. Kulkarni, Paul Rakesh, Awadut Gajendra Giri
  • TETRAHYDRO-BENZOAZEPINE GLYCOSIDASE INHIBITORS
    Publication number: 20220380358
    Abstract: Compounds of formula (I?), wherein A, R1, R2, T1, T2, T3, T4, L, W, Z, R??, m and n have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
    Type: Application
    Filed: August 22, 2019
    Publication date: December 1, 2022
    Inventors: Anna QUATTROPANI, Santosh S. KULKARNI, Awadut Gajendra GIRI, Grant Wishart, Paul RAKESH
  • FUSED GLYCOSIDASE INHIBITORS
    Publication number: 20220143042
    Abstract: This application pertains to compounds of formula (I) wherein A, Z, E, R1, R2, m and n have the meaning according to the claims, and the compounds can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
    Type: Application
    Filed: February 21, 2020
    Publication date: May 12, 2022
    Inventors: Anna QUATTROPANI, Santosh S. KULKARNI, Paul RAKESH
  • PYRROLIDINE GLYCOSIDASE INHIBITORS
    Publication number: 20210213005
    Abstract: Compounds of formula (I), wherein A, W, R3b, Z and p have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
    Type: Application
    Filed: August 22, 2019
    Publication date: July 15, 2021
    Inventors: Anna QUATTROPANI, Grant WISHART, Santosh S. KULKARNI, Paul RAKESH
  • SPIRO COMPOUNDS AS GLYCOSIDASE INHIBITORS
    Publication number: 20210206766
    Abstract: Compounds of formula (I), wherein A, R, L, Z, Q1, Q2 and n have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
    Type: Application
    Filed: August 22, 2019
    Publication date: July 8, 2021
    Inventors: Anna QUATTROPANI, Santosh S. KULKARNI, Paul RAKESH, Awadut Gajendra GIRI